Given that BRAF, CRAF, BRAF+CRAF and MEK1+2 double knock-down had an adverse effect on HCT116 cell proliferation and tumor growth, we examined the effect of targeting these genes on cell cycle progression. The gene discussed is MAP2K1; the disease is neoplasm.